They don't make one magic pill that cures all ailments but if they there was one that worked on penny stocks....
For XMDC that one magic pill would be Paul closing the BioHarp Asset purchase. 99% of all negative or nervous posts here are about when the deal will close or about the stock price. One simple PR announcing that XMDC is now the proud owner of BioHarp. That they have transfered all patents, software, assets, and proprietary information relating to the BioHarp Nano Sensor imaging device into XMDC's control. The stock price will take care of itself and we can all go back to looking to the future and discussing things like this:
BioHarp is a cutting-edge medical imaging device that utilizes a non-invasive approach to detect inflammation in the human body on a cellular level. The device uses a complex scanning program that deciphers inflammation in the body's organs through a bio-sensory system and allows early detection and diagnosis of potentially life threatening diseases. This hand-held diagnostic device is the first of its kind that can effectively scan the body and deliver a comprehensive report that can assist any physician in determining the proper course of treatment for patients in the EARLY STAGES of potentially life threatening diseases.
Unlike CT Scans, MRIs and other similar testing devices, the BioHarp penetrates to the cellular level to detect inflammation differences in the cells. The resulting scan of the body can detect early disease states such as diabetes, liver damage, and other organ problems that, when treated at this early stage, can assist managed care companies, physicians, and insurance companies in increasing morbidity rates and lowering health costs significantly.
